Choksi Laboratories Current Share Price | Choksi Laboratories Stock Screener
CHOKSILA
Healthcare Service Provider
Choksi Laboratories Current Stock Price Today
Live Share Price BSE
₹198.05
▼
-3.40 (-1.69%)
As of September 18, 2026, the live Choksi Laboratories share price (BSE: CHOKSILA) is ₹198.05, down 1.69% from the previous close, with shares trading between ₹192.05 and ₹205.00 in today's trading session, and a 52-week range of ₹89.65–₹209.90.
Browse CHOKSILA cash flow statement to support your investment research.
Use the Choksi Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Choksi Laboratories Market Cap
₹132.69 Cr.
CHOKSILA P/E Ratio (TTM)
58.71
Choksi Laboratories P/B Ratio
4.96
EPS (TTM)
₹2.82
Dividend Yield
-
Debt to Equity
1.29
CHOKSILA 52 Week High
₹209.90
Choksi Laboratories 52 Week Low
₹89.65
Operating Margin
27.00%
Profit Margin
4.17%
CHOKSILA Revenue (TTM)
₹48.00
EBITDA
₹13.00
Net Income
₹2.00
Total Assets
₹72.00
Total Equity
₹26.00
Choksi Laboratories Current Share Price Chart
Track the current Choksi Laboratories share price and stock price with an interactive chart. Analyse CHOKSILA price trends, trading volume, historical performance, and volatility across different timeframes — the complete Choksi Laboratories stock quote in one place.
Choksi Laboratories Company Profile - Fundamental Screener
Screen Choksi Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for CHOKSILA shares.
Sector
Healthcare Services
Industry
Healthcare Service Provider
Sub-Sector
Healthcare Service Provider
Segment
E
ISIN
INE493D01013
Choksi Laboratories Balance Sheet Screener
Screen CHOKSILA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 72 | 65 | 62 | 60 | 64 | 66 | 65 | 55 | 45 | 41 |
| Current Assets | 19 | 16 | 15 | 14 | 14 | 13 | 17 | 16 | 15 | 13 |
| Fixed Assets | 52 | 48 | 43 | 45 | 47 | 50 | 33 | 35 | 29 | 22 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 23 | 18 | 21 | 27 | 31 | 32 | 30 | 18 | 7 | 5 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 26 | 24 | 22 | 21 | 18 | 18 | 20 | 24 | 22 | 21 |
| Share Capital | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 | 7 |
| Reserves & Surplus | 19 | 17 | 15 | 14 | 11 | 11 | 13 | 17 | 15 | 14 |
Choksi Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Choksi Laboratories income statement and profit fundamentals.
Analyze CHOKSILA quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Choksi Laboratories share price evaluation.
| Item | None-None | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48 | 46 | 42 | 37 | 35 | 30 | 26 | 29 | 34 | 31 | 30 | 22 | 23 |
| Expenses | 34 | 34 | 31 | 27 | 24 | 21 | 22 | 25 | 27 | 24 | 24 | 17 | 17 |
| EBITDA | 13 | 12 | 11 | 10 | 11 | 9 | 5 | 3 | 8 | 7 | 6 | 5 | 6 |
| Operating Profit % | 27.00% | 26.00% | 27.00% | 28.00% | 30.00% | 30.00% | 16.00% | 10.00% | 22.00% | 21.00% | 17.00% | 23.00% | 23.00% |
| Depreciation | 7 | 7 | 7 | 6 | 6 | 5 | 5 | 5 | 4 | 3 | 3 | 3 | 3 |
| Interest | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 |
| Profit Before Tax | 3 | 3 | 2 | 2 | 4 | 0 | -3 | -6 | 2 | 2 | 1 | 1 | 1 |
| Tax | 1 | 1 | 1 | 1 | 1 | 0 | 0 | -2 | 1 | 1 | 0 | 0 | 1 |
| Net Profit | 2 | 2 | 2 | 1 | 3 | 0 | -3 | -4 | 2 | 1 | 1 | 1 | 1 |
| EPS | 3.10 | 2.82 | 2.19 | 1.59 | 4.61 | 0.30 | -3.74 | -5.58 | 2.30 | 1.93 | 1.28 | 1.04 | 1.27 |
Choksi Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen CHOKSILA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 8 | 12 | 12 | 8 | 8 | 6 | 3 | 7 | 6 | 7 |
| Investing Activities | -7 | -8 | -7 | -1 | -3 | -8 | -14 | -10 | -5 | -2 |
| Financing Activities | -1 | -4 | -5 | -8 | -5 | 2 | 11 | 2 | -1 | -5 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | 0 |
Choksi Laboratories Shareholding Pattern Screener
See Choksi Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Choksi Laboratories promoter holding and ownership changes for CHOKSILA on TickJournal.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% | 31.48% |
| FII Holding | 6.03% | 7.02% | 1.94% | 4.31% | 5.69% | 5.69% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 49.44% | 49.42% | 52.67% | 49.58% | 48.77% | 49.07% | 60.01% | 60.70% |
| Other Holding | 13.05% | 12.08% | 13.92% | 14.63% | 14.05% | 13.76% | 8.51% | 7.82% |
| Shareholder Count | 4,011 | 3,945 | 4,162 | 4,167 | 4,067 | 4,057 | 4,187 | 4,051 |
Choksi Laboratories Share Dividend Screener - Share Yield Analysis
Check Choksi Laboratories dividend history with payout and yield data.
View Choksi Laboratories dividend details including ex-dates and amounts for CHOKSILA stock.
Choksi Laboratories Stock Index Membership
See which indices include Choksi Laboratories stock.
Check CHOKSILA index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Choksi Laboratories Market Events Screener - Corporate Actions
Get Choksi Laboratories corporate actions including splits, bonuses, and buybacks.
Check Choksi Laboratories stock events that may affect CHOKSILA share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-18 | 2026-09-18 | Annual General Meeting | NA | 63.97% |
| 2026-08-13 | 2026-08-13 | Quarterly Result Announcement | NA | -5.22% |
| 2026-05-25 | 2026-05-25 | Quarterly Result Announcement | NA | 27.88% |
| 2026-02-07 | 2026-02-07 | Quarterly Result Announcement | NA | -3.31% |
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -5.25% |
| 2025-09-16 | 2025-09-16 | Annual General Meeting | NA | -12.03% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | 14.87% |
| 2025-06-07 | 2025-06-07 | Quarterly Result Announcement | NA | 28.65% |
| 2025-05-29 | 2025-05-29 | Quarterly Result Announcement | NA | -0.27% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 0.44% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 9.28% |
| 2024-09-21 | 2024-09-21 | Annual General Meeting | NA | 13.51% |
Choksi Laboratories Competitors Screener - Peer Comparison
Screen CHOKSILA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Dr. Lal Path Labs | 32,002 | 58.88 | 2,864 | 12.11% | 510 | 53.50 |
| Vijaya Diagnostic Centre | 15,455 | 82.34 | 835 | 19.34% | 173 | 58.30 |
| Metropolis Healthcare | 12,139 | 61.01 | 1,671 | 24.15% | 191 | 54.18 |
| Thyrocare Technologies | 8,749 | 50.45 | 846 | 20.48% | 163 | 38.82 |
| Nephrocare Health Services | 7,680 | 88.34 | 1,023 | 32.93% | 77 | 68.67 |
| Krsnaa Diagnostics | 1,784 | 18.74 | 773 | 4.05% | 106 | 47.23 |
| Suraksha Diagnostic | 1,686 | 48.71 | 314 | 22.55% | 31 | 55.15 |
| 3B BlackBio DX | 1,219 | 22.06 | 142 | 27.17% | 61 | 56.62 |
| One Global Service Provider | 1,056 | 14.36 | 498 | 237.06% | 69 | 45.33 |
| Health X Platform | 980 | -37.45 | 1,319 | 12.68% | -3 | 55.59 |
Choksi Laboratories Company Announcements - News Screener
Screen CHOKSILA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-08-27 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-27 | Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants | - |
| 2026-08-25 | Reg. 34 (1) Annual Report. | - |
| 2026-08-25 | Submission Of Notice Convening 33Rd Annual General Meeting Of The Company | - |
| 2026-08-21 | Intimation Under Regulation 30 For Inspection Of USFDA | - |
| 2026-08-21 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-14 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-13 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-08-13 | Submission Of Financial Results For The Quarter Ended 30Th June 2026 | - |
| 2026-08-13 | Board Meeting Outcome for Board Meeting Held On 13.08.2026 | - |
| 2026-08-05 | Board Meeting Intimation for Meeting Of Directors To Be Held On 13Th August 2026 | - |
| 2026-08-04 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-03 | Announcement under Regulation 30 (LODR)-Change in RTA | - |
| 2026-07-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-06-26 | Closure of Trading Window | - |
| 2026-05-26 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-05-25 | Compliances-Reg.24(A)-Annual Secretarial Compliance | - |
| 2026-05-25 | Result For The Quarter And Year Ended 31.03.2026 | - |
| 2026-05-25 | Board Meeting Outcome for Meeting Of Board Of Directors Held On 25.05.2026 | - |